Fibrosis and cirrhosis of liver
Chapter 11:Diseases of the digestive system
ICD-10 K74 is a used to indicate a diagnosis of fibrosis and cirrhosis of liver.
K74 encompasses fibrosis and cirrhosis of the liver, conditions characterized by the progressive replacement of healthy liver tissue with scar tissue (fibrosis) and the eventual development of cirrhosis, which can lead to liver failure. Clinically, patients may present with symptoms such as fatigue, jaundice, ascites, and abdominal pain. The liver, a vital organ involved in metabolism, detoxification, and synthesis of proteins, can be severely impacted by these conditions. Disease progression typically follows a chronic course, often stemming from underlying causes such as chronic hepatitis B or C infection, alcohol abuse, or non-alcoholic fatty liver disease (NAFLD). Diagnostic considerations include liver function tests, imaging studies (ultrasound, CT, MRI), and liver biopsy to assess the degree of fibrosis. Early detection and management are crucial to prevent complications such as portal hypertension and hepatocellular carcinoma.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K74 covers various stages of liver fibrosis and cirrhosis, including compensated and decompensated cirrhosis, as well as specific types of fibrosis related to chronic liver diseases.
K74 should be used when there is clear evidence of liver fibrosis or cirrhosis, particularly when differentiating from other liver conditions such as hepatitis or fatty liver disease.
Documentation should include liver function test results, imaging studies, biopsy reports, and a thorough history of the patient's liver disease progression and treatment.
